Leucomycin-induced acute generalized exanthematous pustulosis complicated with pitting edema of the legs  by Hung, Chu-Ju et al.
lable at ScienceDirect
DERMATOLOGICA SINICA 33 (2015) 157e159Contents lists avaiDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comCASE REPORTLeucomycin-induced acute generalized exanthematous pustulosis
complicated with pitting edema of the legs
Chu-Ju Hung 1, 2, Jen-Jung Cheng 1, 2, Po-Ju Lai 1, 2, Wea-Lung Lin 2, 3, Yu-Ping Hsiao 1, 2, 4, *
1 Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan
2 School of Medicine, Chung Shan Medical University, Taichung, Taiwan
3 Department of Pathology, Chung Shan Medical University Hospital, Taichung, Taiwan
4 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwana r t i c l e i n f o
Article history:
Received: Jun 19, 2014
Revised: Oct 13, 2014
Accepted: Oct 26, 2014
Keywords:
acute generalized exanthematous
pustulosis (AGEP)
kitasamycin
leg edema
leucomycinConﬂicts of interest: The authors have no conﬂict
article and there was no signiﬁcant ﬁnancial support
inﬂuenced its outcome.
* Corresponding author. Department of Dermato
University Hospital, No 110, Section 1, Chien-Kuo North
E-mail address: missyuping@gmail.com (Y.-P. Hsia
http://dx.doi.org/10.1016/j.dsi.2014.10.004
1027-8117/Copyright © 2014, Taiwanese Dermatologia b s t r a c t
Acute generalized exanthematous pustulosis (AGEP) is characterized by fever, sterile nonfollicular pus-
tules, and neutrophilia. More than 90% of cases of AGEP are induced by antibiotics such as amino-
penicillins and macrolides. However, little is known about the side effects associated with leucomycin. To
the best of our knowledge, the following case is the ﬁrst one reporting leucomycin-induced AGEP. The
case presented here is of a 43-year-old man who suffered from generalized pustulosis and severe leg
edema 2 days after taking leucomycin for an upper respiratory tract infection. With discontinuation of
leucomycin and a short course of systemic steroid treatment, these symptoms were gradually relieved.
Copyright © 2014, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Acute generalized exanthematous pustulosis (AGEP) was ﬁrst
described by Baker and Ryan1 in 1968, and was later identiﬁed by
Beylot et al2 as an adverse drug eruption in 1980. AGEP is a rare
adverse drug reaction,with the incidence of ﬁve cases permillionper
year.3 Most common triggers for AGEP are drugs, although it can also
be attributed to viral infections or hypersensitivity to mercury. The
offending drugs in Europe are different from those in Taiwan ac-
cording to the Europe severe cutaneous adverse reactions (Euro-
SCAR) study3 and a retrospective study by Lee and Chung4 in Taiwan.
Leucomycin, also called kitasamycin, is a 16-member macrolide that
binds to bacterial ribosomal RNA and inhibits protein biosynthesis.5Case Report
An otherwise healthy 43-year-old man was admitted due to the
desquamation of skin on the trunk and four limbs, especially the
ﬂexural areas, and some minute nonfollicular pustules on ans of interest relevant to this
for this work that could have
logy, Chung Shan Medical
Road, Taichung 402, Taiwan.
o).
cal Association. Published by Elseverythematous background with severe pitting edema of the bilat-
eral lower limbs (Figure 1).
Seven days prior to this admission, the patient had an upper
respiratory tract infection, and received prophylline 100 mg,
procaterol hydrochloride 25 mg, ambroxol hydrochloride 30 mg,
and cimetidine 200 mg four times per day for 3 days. Because of
persistent symptoms of coughing and nasal congestion, the
physician added leucomycin 100 mg four times per day to the
patient's treatment regimen. Based on the statement from his
primary care physician, the patient had previously taken these
drugs except for leucomycin. After taking leucomycin 100 mg four
times per day for 2 days, generalized exanthems studding with
nonfollicular pustules developed and was accompanied by fever
up to 38C. Subsequently, the trunk erythema soon turned into a
large area of desquamation, but the fever and legs edema were
persistent (Grade 2, depth of 0.25~0.5 inches6). The legs edema
resulted in tenderness and difﬁculty in walking. Thus, he came to
our hospital for help.
On physical examination, he had a fever (38.3C) with blood
pressure of 120/62 mmHg. The electrocardiogram showed sinus
tachycardia (108 beats/min). The blood and chemistry test revealed
leukocytosis (15,500 cells/mL) and increasing neutrophils (9145
cells/mm3), but renal, thyroid, and liver function were normal. The
echocardiography showed preserved left ventricular systolic func-
tion and normal structural heart. The conjunctivae and oral and
genital mucosae were intact and the Nikolsky sign was negative.ier Taiwan LLC. All rights reserved.
Figure 1 Clinical photographs of a 43-year-old man with acute generalized exanthematous pustulosis. (A) Typical superﬁcial postpustular desquamation accentuated on ﬂexural
areas (arrows: neck, axilla, and inner elbow). (B) Nonfollicular, pinhead-sized pustules on a background of edematous erythema.
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pus cultures, and blood cultures were negative.
A skin biopsy showed subcorneal pustules, dermal edema with
mixed inﬂammatory cells, and perivascular inﬁltrate of neutrophils
and eosinophils (Figure 2). Direct immunoﬂuorescence was nega-
tive. AGEP was deﬁnite with a score of 12 based on the scoring
system used in the EuroSCAR study group.3,7 Diagnosis impression
of leucomycin-induced AGEP complicated with legs edema was
made. The skin lesions were relieved after discontinuation of leu-
comycin and after intravenous steroid injection (methylpredniso-
lone 40 mg every 8 hours) for 5 days. The legs edema resolved, and
the circumference of legs reduced from 43 cm to 40 cm after a short
course of diuretics (furosemide 40 mg daily).
Discussion
AGEP is caused by systemic drugs in > 90% of cases. Antibiotics
induced AGEP generally has a short latency period (< 2 days) from
drug administration to pustule eruption, comparedwith 11 days for
all other associated drugs.3,8 According to the clinical and histo-
logical ﬁndings reported in our case, the quick desquamation after
the pustules onset may indicate other diseases, such as acute
generalized pustular psoriasis (GPP, von Zumbusch type), staphy-
lococcal scalded skin syndrome (SSSS), and Stevens-Johnson
syndrome/toxic epidermal necrolysis (SJS/TEN).7 Because of the
quick onset, rapid relief, and lack of previous similar history of
generalized pustules, AGEP was the more probable diagnosis rather
than pustular psoriasis.7e9 Because of no mucosa involvement and
the absence of epidermal necrosis on pathology, SJS/TEN could be
ruled out.8,9 As for the SSSS, the onset is usually in childhood and
the pathology could show subcorneal layer separation.10,11 TheFigure 2 Photomicrographic ﬁndings. (A) Spongiform subcorneal pustule with papillary der
eosinophils inﬁltrate the superﬁcial dermis (hematoxylin and eosin; original magniﬁcationclinical and pathological features can be used to identify the dif-
ferences between these conditions.5e9
In our case, the AGEP occurred 2 days after taking leucomycin,
which had not been previously taken, and the symptoms subsided
gradually after cessation of the drug. These ﬁndings indicate that
leucomycin is the culprit. The most common causative drugs for
AGEP in Taiwan identiﬁed by Lee and Chung4 were aminopenicillin,
cephalosporin, quinolones, and Chinese herbs.4 Offending drugs
related to AGEP in Europe were pristinamycin, ampicillin/amoxi-
cillin, quinolones, (hydroxyl) chloroquine, anti-infective sulfon-
amides, terbinaﬁne, and diltiazem.3 However, leucomycin was not
mentioned in the literature review.
Leucomycin, also called kitasamycin, is a complex of 16-member
macrolides discovered by Professor Toju Hata12 in 1953 in Japan. It
is composed of leucomycin A1, A3, A4, A5, A6, A7, A8, A9, and A13.13
Although leucomycin falls into the category of macrolides, it is
different from the traditional macrolides (erythromycin, azi-
thromycin, spiramycin, and pristinamycin IA) in the carbon struc-
ture and the side chains of the formula. The structural differences
make leucomycin amacrolide with less drug interactions and lower
gastrointestinal effects (Table S1).5,12,14,15 For example, it does not
conjugate to cytochrome P-450 of the liver, thus it does not affect
the excretion of other drugs.14,15 The side effect of leucomycin is
uncommon, whereas skin rash, liver function abnormality, nausea,
vomiting, and diarrhea are mentioned.5
Leucomycin binds to 50s bacterial ribosomal RNA and inhibits
protein biosynthesis.5 It has antimicrobial activity against a wide
spectrum of pathogens, including gram-positive bacteria, part of
negative bacteria, leptospira, rickettsia, mycoplasma, and chla-
mydia, etc.5,12,13 It inhibits the efﬂux pumps of resistant spectrum
Streptococcus pneumoniae that other macrolides cannot do.5mis edema (hematoxylin and eosin; original magniﬁcation, 100). (B) Neutrophils and
, 400).
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inﬂuenza A viral infection and inhibit disease progression.16 These
may indicate a wider use of leucomycin in the future. We hereby
report the ﬁrst case of leucomycin-induced AGEP in the literature to
raise awareness of such a side effect.
Systemic involvement in AGEP includes facial edema, and liver
and kidney dysfunction.4,17 Bilateral legs pitting edema was never
previously mentioned as a clinical symptom of AGEP in the litera-
ture. Our patient indeed had Grade 2 edema accompanied by
walking difﬁculty and tenderness. Cardiac, renal, liver, and thyroid
function were all within normal limits, and the patient's blood al-
bumin showed a slight decrease. The causative etiology of edema
might be attributed to a severe inﬂammatory response to
increasing vascular permeability and the elevation of venous
pressure by a persistent standing posture because of the patient's
occupation as a tour guide. The patient's edema regressed after a
diuretic was prescribed, and cardiac as well as the renal function
were normal at follow-up.
AGEP is a rare but important drug reaction. For optimal
outcome, prompt recognition and discontinuation of related drugs
are important. Because of the benign, self-limited course of the
disease, a speciﬁc treatment especially systemic corticosteroid
treatment is usually not necessary.7 This is the ﬁrst case of leuco-
mycin-induced AGEP in the literature. Physicians should be aware
of such side effects of using the drug.
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